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The structure of blood clots has recently become ahot topic in the scientific and medical literature. Asearch on PubMed for ‘clot structure’ results in
>1,000 publications in the last 25 years, with >400 in the
last five years alone. The reason for this surge in studies
of the structure of blood clots is that dense clot structures
that are resistant to fibrinolysis have been associated with
both arterial and venous thrombosis (reviewed by Undas
and Ariëns1), and lead to poor outcome in prospective
studies of arterial2 and venous3 thrombotic disease.
Furthermore, mechanisms from cellular contributions
from platelets, red blood cells (RBC)4  and white blood
cells (neutrophils producing extracellular traps or NET5) to
clot structure are increasingly being understood.
However, many previous studies have focused on indi-
vidual clot components and their roles in clot structure
and function, largely using either in vitro or in vivomethod-
ology. Holistic approaches to study clot structure in
thrombi obtained from patients with thrombosis have
until now been few and far between, and are increasingly
needed to place studies of individual clot structures into
clinical context.  
In the current edition of Haematologica, Staessens et al.6
studied the internal organization of 177 thrombi collected
from endovascularly treated ischemic stroke patients.
The objective of this study was to gain further under-
standing of the composition of stroke thrombi by histo-
logically analyzing the internal organization of their
structural components, including fibrin, RBC, von
Willebrand factor (vWF), platelets, leukocytes and DNA.
Using bright field and fluorescence microscopy, the
authors observed that stroke thrombi are very heteroge-
neous in nature in two ways. First, they differ distinctly
from each other in size, shape, and color. Second, within
each thrombus there is considerable heterogeneity, with
different areas or segments of the thrombus demonstrat-
ing different structural components. Based on the major
structural components that are dominant in the thrombi,
they were classified into two distinct types: RBC- and
platelet-rich areas of the thrombus (Figure 1). Platelet-rich
areas are composed of dense fibrin structures, platelets,
vWF, leukocytes and extracellular DNA, whereas compo-
sition of RBC-rich areas is less complex, with packed RBC
and a thin fibrin meshwork filling the gaps in between
the packed RBC as the main structural components.
Staessens et al.6 further quantified the relative contribution
of each type of thrombus area. It appears that the contri-
bution of both types varies significantly across all throm-
bi analyzed. For most thrombi, both regions are dispersed
throughout, although some thrombi have more clearly
defined boundaries, with RBC-rich regions surrounded
by platelet-rich regions. The findings obtained in this
study provide interesting insight into the composition
and internal organization of stroke thrombi and could be
helpful in furthering our understanding of thrombolysis
resistance and developing new therapies for acute
ischemic stroke. Furthermore, knowledge of the structur-
al composition of thrombi may be important for the rela-
tive success of mechanical thrombectomy. 
This study makes important and valuable contributions
to the previous efforts in the identification of thrombi
composition, many of which were based on scanning
electron microscopy.7-12 There are a number of significant
strengths of the current study. First, compared to previous
studies,10,11 this is the first study to image thrombi
obtained from patients with stroke with such detail,
including visualization of multiple structural components
of thrombi: fibrin, vWF, DNA and blood cells at the same
time. Second, the use of immunofluorescence in this
study overcomes limitations of conventional staining and
generated stunning images, which allow for accurate
localization of specific components and provide impor-
tant structural insight of stroke thrombi both at cellular
and molecular levels. In particular, compared with previ-
ous studies using conventional staining,7,12-14 more detailed
organization and structural features of platelet, vWF and
fibrin meshes in thrombi were demonstrated.
Interestingly, the polyhedral morphology of RBC inside
thrombi is also defined in these images, reminiscent of
the tightly packed polyhedrocytes previously observed in
thrombi formed in vivo and in vitro.15,16 Furthermore, the
observation that extracellular DNA and leukocytes were
located primarily in the platelet-rich areas, and close to
the interface of these areas with others, emphasizes their
potential crucial role in the rt-PA resistance observed in
patients. 
While this study makes big strides forward in our
understanding of thrombus structure and function, some
limitations remain. The first is that only microscopic
methods were used to study the histological composition
of thrombi, while there are no data on mechanical or
functional properties of the thrombi. Previous studies on
mechanical properties have shown that fibrin-rich clots
have a higher friction than RBC-rich clots,17 and the
increased percentage of RBC in the clot affects fibrin net-
work heterogeneity and clot stiffness,18 indicating that
differences in thrombi composition may be strongly
linked to the mechanical properties of these clots. The
mechanical properties of thrombi may in turn impact on
the degree of embolization on one hand, and the success
rate of thrombus retrieval by endovascular thrombecto-
my on the other. A comprehensive study of the mechan-
ical properties of thrombi in patients is needed to further
our understanding of the possible correlations between
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thrombus composition and their mechanical properties,
which would be advantageous in guiding the develop-
ment of new generations of stent retrievers, as well as the
selection of optimal thrombectomy therapy for patients.
Another limitation of current studies regards the handling
and storage of thrombus samples from patients. The
thrombi obtained from thrombectomy are likely to
undergo structural changes during or after the retrieval
process. It is usually not possible to tell if the whole clot
has been retrieved, or only fragments of it, and which
parts represent the ‘head’ of the clot or the ‘tail’.
Furthermore, the internal organization and composition
are probably modified by chemical fixation, air exposure
or physical manipulation. A standard thrombus process-
ing method needs to be developed to standardize those
influences on thrombi during and after the retrieval
process.19,20 In addition, the thrombi analyzed in this
study only represent those that were successfully
retrieved by thrombectomy, and were obtained from
patients who received either prior rt-PA treatment or not.
Future histological studies focusing on thrombi that are
resistant to thrombectomy and rt-PA treatment would
open a new window for advancing the treatment of acute
ischemic stroke using intravascular approaches. 
Intriguing new questions are also raised by the current
study. For example, the role of polyhedrocytes observed
in the thrombus remains poorly characterized.
Polyhedrocytes are formed in contracted blood clots and
thrombi due to the compression by activated contractile
platelets pulling on fibrin. Remarkably, polyhedrocytes
were first described in German by Gottlob et al. In 1970,21
Cynes et al. further characterized polyhedral erythrocytes,
and described their occurrence in clots made in vitro and
in thrombi obtained by thrombectomy from patients
with myocardial infarction.15,16,22 The occurrence of poly-
hedrocytes in coronary thrombi was independently con-
firmed by Zalewski et al.23 These studies suggest that
polyhedrocytes play important roles in thrombi, by form-
ing a near impermeable seal that impairs diffusion of fib-
rinolytic enzymes into thrombi, leading to reduced
thrombolysis. However, despite the multiple observa-
tions and efforts made by previous studies, detailed
mechanisms of polyhedrocyte formation in contracted
thrombi and their clinical and pathological implications
are still underappreciated. Furthermore, thrombus con-
traction, usually associated with the presence of polyhe-
drocytes, is another interesting topic. It has been reported
that patients with VTE and PE have significantly reduced
Figure 1. Schematic representation of the composition and organization of ischemic stroke thrombi as reported by Staessens et al.6 (Top) Red blood cell (RBC)
rich area. This area mainly consists of packed RBC (polyhedrocytes) surrounded by thin fibrin fibers, which fill (or ‘cement’) the space between cells. Leukocytes
(neutrophils) are also observed in these areas, but are less abundant. (Bottom) Platelet-rich area. Multiple structural components are found in this area, including
platelets, thick fibrin bundles, von Willebrand factor (vWF), leukocytes (neutrophils) and extracellular DNA (due to NETosis). 
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clot contraction compared to healthy donors,24 suggesting
important associations between changes in the ability of
blood clots to contract and the incidence of thromboem-
bolism. These observations indicate polyhedrocytes as
potential clinical markers of thromboembolism or targets
for therapeutic intervention. 
How the structure of the stroke thrombi in the report
by Staessens et al.6 compares to other arterial or venous
thrombi is another intriguing point. While arterial and
venous thrombosis may be closely associated,25,26 they are
triggered by different initiating mechanisms which may
result in differences in the internal structure and compo-
sition of the thrombi.27 Arterial thrombi occur under high
shear stress, leading to platelet-rich clots that form
around ruptured atherosclerotic plaques and the damaged
endothelium. In contrast, venous thrombi occur under
low shear stress and mostly on an intact, although likely
inflamed, endothelium. Compared to arterial thrombi,
venous thrombi are thought to favor the formation of
clots that are fibrin-rich, encapsulating a large number of
RBC in addition to activated platelets. However, despite
these differences in initiating mechanisms, recent studies
on structural characteristics of arterial thrombi challenge
the concept that arterial thrombi are platelet-rich and
venous thrombi are RBC-fibrin rich, since the arterial
thrombi also contained large amounts of fibrin and RBC
in addition to platelets.16,23 The current study by Staessens
et al.6 also shows significant areas that are RBC- and fib-
rin-rich in arterial stroke thrombi. Therefore, differences
in the composition of arterial and venous thrombi are
likely subtler and may not be as distinct with regards to
relative fibrin, platelet and RBC contents as previously
thought. Is the clot organization observed in this work for
stroke thrombi also applicable to thrombi obtained from
other types of thrombosis? More in-depth studies using
thrombi obtained from other arterial or venous sources
would help answer this very question. 
The insightful imaging of thrombi from patients with
stroke presented in this paper from our Belgian colleagues
clearly contributes to our understanding of the cellular
and molecular make-up of thrombi. It also sets an elegant
example for future analysis of thrombi from other vascu-
lar beds. Once more data are generated regarding the
structural heterogeneity of thrombosis in both the venous
and arterial circulation, we will be able to associate these
findings with in vitro blood clot structure from systemic
samples, providing tantalizing opportunities for new
diagnostic tools. In addition, once the functional conse-
quences of different thrombi structures on the behavior
of these thrombi, their stability and future outcome is
better documented, we should be able to improve inter-
ventional and medical treatment of thrombosis, and
explore theranostics or other improved personalized
approaches based on the nature of the thrombus that
needs to be removed.
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